从肝论治隔药灸治疗便秘型肠易激综合征疗效观察

摘要

Objective To observe the clinical efficacy of herb-partitioned moxibustion (HPM) for constipation-predominant irritable bowel syndrome (C-IBS) from the perspective of regulating liver. Method Forty C-IBS patients were randomized into a HPM group and a Western medication group. The HPM group was intervened by HPM from the perspective of regulating liver, while the Western medication group was by lactulose, both for 4 weeks. The clinical efficacies were then compared between the two groups. Result In the HPM group, 13 subjects were recovered, 3 showed markedly effective, 1 showed effective, and 3 failed; in the Western medication group, 7 subjects were cured, 3 showed markedly effective, 2 showed effective, and 8 failed. The therapeutic efficacy of the HPM group was significantly superior to that of the Western medication group (P<0.01). Conclusion HPM by regulating liver can produce a significant clinical efficacy in treating C-IBS.%目的：观察从肝论治隔药灸治疗便秘型肠易激综合征的临床疗效。方法将40例便秘型肠易激综合征患者随机分为隔药灸组、西药组。隔药灸组使用从肝论治隔药灸，西药组使用乳果糖治疗，治疗4星期。观察比较两组的临床疗效。结果隔药灸组治愈13例，显效3例，有效1例，无效3例；西药组治愈7例，显效3例，有效2例，无效8例。隔药灸组疗效显著优于西药组(P＜0.01)。结论从肝论治隔药灸治疗便秘型肠易激综合征能获得明显的临床疗效。